Welcome to our dedicated page for TERADYNE SEC filings (Ticker: TER), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TERADYNE's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TERADYNE's regulatory disclosures and financial reporting.
Form 144 filed for Teradyne, Inc. (TER) reporting a proposed sale of 554 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $70,020.06, and an approximate sale date of 09/22/2025 on NASDAQ. The filing lists 159,073,532 shares outstanding for the issuer.
The 554 shares to be sold were acquired as restricted stock vesting from the issuer on 01/27/2025, 01/28/2025 and 01/29/2025 and were paid as compensation. The filing also discloses three prior sales by Gregory S. Smith during the past three months: 554 shares on 07/30/2025 for $58,574.42, 554 shares on 08/12/2025 for $58,724.00, and 554 shares on 09/12/2025 for $63,710.00.
Teradyne director and President & CEO Gregory Stephen Smith reported a sale of 554 shares of Teradyne common stock on 09/12/2025 at a price of $115 per share. The Form 4 shows 96,438.995 shares remained beneficially owned by Mr. Smith after the reported sale. The filing states the shares were sold under a sales plan adopted February 4, 2025 that was intended to comply with Rule 10b5-1, indicating the transaction followed a prearranged insider trading plan. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Jean Pierre Hathout filed an initial Form 3 reporting beneficial ownership in Teradyne, Inc. (TER) on 09/02/2025. The filing shows 9,551 shares beneficially owned, consisting of 1,713 vested common shares and 7,838 restricted stock units (RSUs) awarded under the companys 2006 Equity and Cash Compensation Incentive Plan. The RSUs convert one-for-one to common shares and vest on defined schedules from 2026 through 2028. Hathout is identified as an officer (President, Teradyne Robotics) and director.
Mercedes Johnson, a director of Teradyne, Inc. (TER), reported a sale of company stock under a pre-established trading plan. The Form 4 shows a transaction on 09/05/2025 in which 625 shares of Teradyne common stock were sold at a price of $120.06 per share. After the sale, the reporting person directly beneficially owned 10,738 shares and indirectly beneficially owned 1,876 shares held by a trust for which she is trustee and sole beneficiary.
The filing notes the sale was made pursuant to a 10b5-1 plan adopted on February 3, 2025. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/09/2025.
Form 144 notice for Teradyne, Inc. (TER): The filer reports an intended sale of 625 common shares through Fidelity Brokerage Services on 09/05/2025 with an aggregate market value of $75,037.50. The securities were acquired by restricted stock vesting on 05/09/2024 and were received as compensation. The filing also discloses prior sales by the same person this year: 1,875 shares sold 07/30/2025 for $198,243.75 and 625 shares sold 08/05/2025 for $66,250.00. The filing states the seller represents there is no undisclosed material adverse information. The total shares outstanding reported are 159,073,532 and the planned sale is on NASDAQ.
Teradyne, Inc. disclosed terms related to an executive separation and upcoming filings. The executive will remain subject to non-compete, non-solicitation and non-disparagement covenants for 12 months following his last day of employment, provided he complies with those restrictions. He is also eligible for a pro-rated 2025 annual cash bonus based on actual performance, which the company expects to pay in early 2026. The company references a Form 10-Q for the quarter ended September 28, 2025, and the document is signed by Ryan E. Driscoll, V.P., General Counsel and Secretary.
Reporting person: Gregory Stephen Smith, who serves as President and CEO and a director of Teradyne, Inc. (TER), reported an insider sale on Form 4. The transaction occurred on 08/12/2025 and was reported on a Form 4 signed by an attorney-in-fact on 08/14/2025. The filing shows 554 shares of Teradyne common stock were sold at a price of $106 per share pursuant to a pre-established Rule 10b5-1 sales plan adopted on February 4, 2025. After the reported sale, the filing shows the reporting person beneficially owns 96,992.995 shares directly.
Teradyne's Form 144 reports a proposed sale of 554 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $58,724 and an approximate sale date of 08/12/2025 on NASDAQ. The filing lists total shares outstanding as 159,073,532, indicating the position is very small relative to the company's capitalization. The securities were acquired by restricted stock vesting on 01/27/2025, and the consideration is recorded as compensation.
The notice also records a prior sale of the same 554 shares on 07/30/2025 for $58,574.42. The form includes the standard Rule 144 representation regarding absence of undisclosed material adverse information and a field for Rule 10b5-1 plan adoption if applicable, though no plan adoption date is provided in the filing.
SEC Form 4 – Teradyne, Inc. (TER)
- Director Mercedes Johnson sold 625 common shares on 08/05/2025 at $106 per share.
- The disposition was made pursuant to a Rule 10b5-1 trading plan adopted 02/03/2025, indicating a pre-scheduled, compliance-driven sale.
- Post-transaction ownership: 11,363 shares held directly; an additional 1,876 shares held indirectly through The Mercedes Johnson Trust.
No derivative securities were reported and no other transactions were disclosed. The 625-share sale represents a small fraction of the director’s total holdings; therefore, the filing appears routine with limited immediate investment significance.